Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Four-Session group program spark motivation to overcome addiction?

NCT ID NCT07658963

Disease control Sponsor: The Catholic University of Korea Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a new four-session group program, called the First Step Program, can be delivered in hospital settings and help people with substance use disorders. The program combines motivational interviewing, acceptance and commitment therapy, and group support to boost motivation to change and reduce cravings. About 20 adults in inpatient care in Korea will participate, completing questionnaires and interviews before, during, and up to three months after the program. Because this is a small pilot study without a comparison group, its main goal is to see if the program is feasible and worth testing in a larger trial.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
First Step Program (behavioral intervention combining motivational interviewing, acceptance and commitment therapy, and group therapy)
What this could lead to
If this program proves feasible and shows early benefits, it could lead to a larger trial testing whether a brief psychosocial intervention helps people with substance use disorders build motivation and reduce cravings.
What could go wrong
This is a very small pilot study with only 20 participants and no comparison group, so any positive findings may not hold up in larger, more rigorous trials. The program is also short (four sessions) and may not produce lasting change.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 20 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 19 to 65 years who can understand the study purpose and procedures and provide written informed consent * Currently hospitalized (inpatient) * Able to communicate and complete questionnaires in Korean * Physically able to participate in program activities * Has completed detoxification treatment * Meets indication thresholds: DAST-10 score \>= 2, URICA-DO precontemplation or contemplation stage, and \>= 2 DSM-5 criteria Exclusion Criteria: * Cognitive impairment that precludes communication * Physical conditions that preclude program participation (e.g., musculoskeletal disorder, severe cardiopulmonary disease) * Acute psychotic symptoms or risk of self-harm or harm to others * At risk of disrupting group activities such that focus group participation is not feasible * Individuals who are inmates or incarcerated at screening are not enrolled; participants who become incarcerated after enrollment are withdrawn

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Substance use disorder (SUD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Substance use disorder (SUD)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Daegu Daedong Hospital

    Daegu, South Korea

  • Incheon Chamsarang Hospital

    Incheon, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.